12 days ago
I do not short shares. I never have and never will but if I am sorely tempted to open a short on Matt Moulding’s THG (THG) at 31.6p, a £524 million market cap. I have always been a bear and so have called this stock as a sell from its 500p IPO in September 2020. Unlike the sell side analysts who kiss Matt Moulding’s posterior and have always done so I have always called this correctly.
2248 days ago
Of course, those who know best will insist that this in no way validates the IP of Optibiotix (OPTI) and is a small deal which will not generate any license (and thus almost all margin with no working capital needed) profits at all. Whatever… So why has it not been announced?
